Table 1.

Patient Characteristics and Correlation Coefficient Values of the Overall Changes in the TCRBV Repertoire of Fetuses Undergoing Diagnostic FBS or IUT

Patient No.DiagnosisNo. of IUTsFirst FBS*Second Analysis*Birth*R2 CD4R2 CD8
IUT patients 
1. Hemolytic disease 21 33 (IUT5) 34 .141 .655 
2. Hemolytic disease 21 32 (IUT4) 34 .348 .769 
3. Hemolytic diseae 31 37 birth 37 .851 .539 
4. Hemolytic disease 32 39 birth 39 .193 .169 
5. Allo-immune thrombocytopenia 28 34 (IUT3) 34 .522 .903 
FBS patients 
6. Growth retardation  —  30 40 40 .940 .468 
7. Congenital heart disease  —  22 39 38 .965 .522 
8. Growth retardation  —  31 38‡‡ 35 .871 .779 
9. Dandy Walker  —  34 37 37 .867 .901 
10. XO mosaic  —  20 40 40 .851 .742 
Patient No.DiagnosisNo. of IUTsFirst FBS*Second Analysis*Birth*R2 CD4R2 CD8
IUT patients 
1. Hemolytic disease 21 33 (IUT5) 34 .141 .655 
2. Hemolytic disease 21 32 (IUT4) 34 .348 .769 
3. Hemolytic diseae 31 37 birth 37 .851 .539 
4. Hemolytic disease 32 39 birth 39 .193 .169 
5. Allo-immune thrombocytopenia 28 34 (IUT3) 34 .522 .903 
FBS patients 
6. Growth retardation  —  30 40 40 .940 .468 
7. Congenital heart disease  —  22 39 38 .965 .522 
8. Growth retardation  —  31 38‡‡ 35 .871 .779 
9. Dandy Walker  —  34 37 37 .867 .901 
10. XO mosaic  —  20 40 40 .851 .742 
*

Given in weeks of gestation.

Peripheral blood was obtained 1 week after birth for analysis of the TCRBV repertoire.

Peripheral blood was obtained 3 weeks after birth for analysis of the TCRBV repertoire.

Close Modal

or Create an Account

Close Modal
Close Modal